Naloxone
Check on psychonaut
3,14-Dihydroxy-17-(p...
Check on isomerdesign
Naloxone
Check on pubchem
Naloxone
Check on drugmap
Naloxone
Check on wiki
Data
InChI: InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2
Synonyms: (-)-Naloxone,HSDB 3279,BDBM50000788,Prestwick1_000111,MLS000069540,l-Naloxone,Morphinan-6-one,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5.alpha.)-,DSSTox_RID_76986,Prestwick3_000111,3,14-dihydroxy-17-(prop-2-en-1-yl)-4,5alpha-epoxymorphinan-6-one,465-65-6,Q282902,Morphinan-6-one, 17-allyl-3,14-dihydroxy-4,5-alpha-epoxy-,NCGC00162267-02, Naloxona,36B82AMQ7N,Narcan,(-)-N-allyl-14-hydroxynordihydroxymorphinan-6-one,(1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one, Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy-(8CI), Naloxone (INN),17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one, Narcan,MLS000736771,DB01183,4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one (naloxone), 17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one, Nalone (TN),1-N-Allyl-14-hydroxynordihydromorphinone,(naloxone) 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one,NSC-70413,(5α)-3,14-Dihydroxy-17-(prop-2-en-1-yl)-4,5-epoxymorphinan-6-one,NCGC00274058-01,SMR000058766,NALOXONE [VANDF],DTXSID8023349,Normorphinone, N-allyl-dihydro-14-hydroxy-, Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)-(9CI), 1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone,[3H]naloxone,(4R,4aS,7aR,12bS)-4a,9-bis(oxidanyl)-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride,EINECS 207-365-7,MORPHINAN-6-ONE, 4,5-EPOXY-3,14-DIHYDROXY-17-(2-PROPENYL)-, 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one,Naloxona,NSC 70413,Naloxonum,Naloxone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,Naloxone [INN:BAN],Naloxone (INN),4aH-8,5-bcd]furan-5(6H)-one, N-allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-,(4R,4aS,7aR,12bS)-4a,9-Dihydroxy-3-(prop-2-en-1-yl)-2,3,4,4a,5,6-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinolin-7(7aH)-one,NALOXONE [WHO-DD],2-(([2-(ETHYLTHIO)-3-PYRIDYL]CARBONYL)AMINO)-4-(METHYLTHIO)BUTANOICACID,(5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propen-1-yl)morphinan-6-one,NALOXONE [USP-RS],Naloxone Nasal Spray,RAM-301,(-)-Naloxone,SPBio_002061, Naloxonum, 17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one,NALOXONE [ORANGE BOOK],NLX,EN 1530 base,3,14-Dihydroxy-17-(prop-2-en-1-yl)-4,5α-epoxymorphinan-6-one,NIOSH/QD2135000,HMS2090F20,NCGC00024674-03,Morphinan-6-one, 4,5-alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-,Kloxxado (naloxone hydrochloride nasal spray),BDBM54795, Naloxonum [INN-Latin], DBL Naloxone (TN),Narcon,4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one, 1-N-Allyl-14-hydroxynordihydromorphinone,NALOXONE [HSDB],17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE,CHEBI:7459, N-Allylnoroxymorphone,7,8-Dihydro-N-allyl-14-hydroxynormorphinone,CAS-465-65-6, Naloxone [INN:BAN],BSPBio_000122, (-)-N-allyl-14-hydroxynordihydroxymorphinan-6-one,Nalone, (5alpha)-3,14-dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one,Morphinan-6-one, 4,5alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-,Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy- (8CI),(5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one,[17-(2,3-3H-2-propenyl)]-4, 5a -epoxy-3,14-dihydroxymorphinan-6-one,4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(naloxone)C2H2O4, L-N-Allyl-7,8-dihydro-14-hydroxynormorphinone,Nyxoid,C07252,DBL Naloxone (TN),Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)-,BIDD:GT0110, EN 1530base,Naloxonum [INN-Latin],(naloxone)4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one, N-Allyl-4,5alpha-epoxy-3,14-dihydroxy-6-morphinanon, Narcanti,17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one, Nalossone,12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one,SCHEMBL34284, 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro(4,5-bcd)furanone,1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone, Nalossone [DCIT],ZINC389747,Morphinan-6-one,5.alpha.-epoxy-3,14-dihydroxy-17-(2-propenyl)-,NSC70413,DBL Naloxone,(-)-N-ALLYL-14-HYDROXYNORDIHYDROMORPHINONE,4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one,QD21350000,465N656,(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride,N-Allyl-4,5alpha-epoxy-3,14-dihydroxy-6-morphinanon,DSSTox_CID_3349,4683B, (5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one,NALOXONE [EMA EPAR],Prestwick2_000111,CHEMBL80,Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- (9CI), Narcan (TN),Naloxona [INN-Spanish],Normorphinone, N-allyl-7,8-dihydro-14-hydroxy-, (-)-,DSSTox_GSID_23349,l-N-Allyl-7,8-dihydro-14-hydroxynormorphinone,PDSP2_001520,Morphinan-6-one,5.alpha.-epoxy-3,14-dihydroxy-,(naloxone)4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one,BRN 1089071,Normorphinone, 7,8-dihydro-N-allyl-14-hydroxy-,EN300-19748912,NALOXONE [INN],17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one,NCGC00024674-02, Narcon,GTPL1676,[N-allyl-2,3-3H]naloxone,BRD-K67511046-001-02-3,D08249,Tox21_112006_1,NALOXONE [MI], 3,14-dihydroxy-17-(prop-2-en-1-yl)-4,5alpha-epoxymorphinan-6-one, N-Allyl-noroxymorphone,Nalossone [DCIT], L-N-Allyl-14-hydroxynordihydromorphinone, DBL Naloxone,Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5.alpha.)-, Naloxona [INN-Spanish],Tox21_112006, 17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one,Prestwick0_000111,cid_5464092,4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(Naxolone),17-Allyl-3,14-dihydroxy-4,5-alpha-epoxymorphinan-6-one,BPBio1_000136,l-N-Allyl-14-hydroxynordihydromorphinone,(5alpha)-3,14-dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one,N-Allyl-noroxymorphone,4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one( Naloxone),SMP1_000205,(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride, L-Naloxone,n-Allylnoroxymorphone,12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro(4,5-bcd)furanone,naloxone,GTPL1638,Nalossone,UNII-36B82AMQ7N, Narcanti (TN),AKOS016009988,BRD-K67511046-003-03-7,Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy-, Naloxone HCl,(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
Estimated data
Solubility: -2.851 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)
Addictivity Prediction: 96.1% (prediction based on www.mdpi.com)
